Ep. 120 - Next-gen NK cells, Plus Woodcock & BMS’s Russian Withdrawal
BioCentury This Week
00:00
FDA's I T Systems Aren't Financing, but It's Affordable
Bristol myers is the first multi national farma to withdraw from russia following that country's invasion of ukraine. The company has a hundred and 70 staff there, but they haven't said that they're going to stop selling their products there. What they've done instead is to shift all their sales to russia to a third party in switzerland. Most of bristol myer's staff have been given an opportunity to move over and become employees of swicks.
Transcript
Play full episode
